A Randomized, Double-blind, Multicenter Trial Comparing Efficacy and Safety of Imipenem/Cilastatin/Relebactam Versus Piperacillin/Tazobactam in Adults With Hospital-acquired or Ventilator-associated Bacterial Pneumonia (RESTORE-IMI 2 Study)
Ivan Titov(Ivano-Frankivsk National Medical University), Luke F. Chen(Merck & Co., Inc., Rahway, NJ, USA (United States)), Joan R. Butterton(Merck & Co., Inc., Rahway, NJ, USA (United States)), Richard G. Wunderink(Northwestern University), Jiejun Du(Merck & Co., Inc., Rahway, NJ, USA (United States)), Katherine Young(Merck & Co., Inc., Rahway, NJ, USA (United States)), Aileen David-Wang(Philippine General Hospital), Matthew L. Rizk(Merck & Co., Inc., Rahway, NJ, USA (United States)), Antoine Roquilly(Nantes Université), Maria C Losada(Merck & Co., Inc., Rahway, NJ, USA (United States)), Amanda Paschke(Merck & Co., Inc., Rahway, NJ, USA (United States)), Daniel González(University of North Carolina at Chapel Hill), Munjal Patel(Merck & Co., Inc., Rahway, NJ, USA (United States)), Michelle Brown(University Hospital of Zurich), Helen W. Boucher(Tufts Medical Center), Keith S. Kaye(Johnson University), Robert Tipping(Merck & Co., Inc., Rahway, NJ, USA (United States)), Nicholas A. Kartsonis(Merck & Co., Inc., Rahway, NJ, USA (United States))
Cited by 232
Related Papers
Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults
|New England Journal of Medicine|2015|3.4k
Community-Acquired Pneumonia Requiring Hospitalization among U.S. Children
|New England Journal of Medicine|2015|1.9k
Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused by <i>Staphylococcus aureus</i>
|New England Journal of Medicine|2006|1.5k
International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia
|European Respiratory Journal|2017|1.4k
Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
|New England Journal of Medicine|2017|1.2k